Evaluation of Trastuzumab Anti-Tumor Efficacy and its Correlation with HER-2 Status in Patient-Derived Gastric Adenocarcinoma Xenograft Models

Systemic therapy for advanced gastric cancer: a clinical practice guideline

(2011) M. MacKenzie et al.   Current Oncology

How will human epidermal growth factor receptor 2-neu data impact clinical management of gastric cancer?

(2011) Sylvie Lorenzen et al.   CURRENT OPINION IN ONCOLOGY

Targeting the HER2 pathway for the therapy of lower esophageal and gastric adenocarcinoma

(2011) Antarpreet Kaur et al.   EXPERT OPINION ON PHARMACOTHERAPY

Trastuzumab: a new treatment option for HER2-positive metastatic gastric and gastroesophageal junction cancer

(2011) Florian Lordick   Future Oncology

HER2 Testing in Gastric Cancer

(2010) Luca Albarello et al.   ADVANCES IN ANATOMIC PATHOLOGY

Advanced gastric cancer – Slow but steady progress

(2010) Derek G. Power et al.   CANCER TREATMENT REVIEWS

The role of HER2 in cancer therapy and targeted drug delivery

(2010) Wanyi Tai et al.   JOURNAL OF CONTROLLED RELEASE

Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial

(2010) Yung-Jue Bang et al.   LANCET

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistry

(2009) Yukie Sato-Kuwabara et al.   BMC CANCER

Trastuzumab for gastric cancer

(2009) Judith Meza-Junco et al.   EXPERT OPINION ON BIOLOGICAL THERAPY

Recent trends of HER-2 testing and trastuzumab therapy for breast cancer

(2009) Masafumi Kurosumi   Breast Cancer

HER2 in gastric cancer: a new prognostic factor and a novel therapeutic target

(2008) C. Gravalos et al.   ANNALS OF ONCOLOGY

Assessment of a HER2 scoring system for gastric cancer: results from a validation study

(2008) M Hofmann et al.   HISTOPATHOLOGY

From Human to Mouse and Back: 'Tumorgraft' Models Surge in Popularity

(2008) K. Garber   JNCI-Journal of the National Cancer Institute